This provider's $53.6M in total Medicare payments ranks in the 98th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 25127% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 4887% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $51.39 | $23.80 | 2.16x | $27.59 | $26.3K | 1.1K | 5 |
| 2015 | $55.06 | $25.57 | 2.15x | $29.49 | $1.3M | 51.3K | 10 |
| 2016 | $992.58 | $160.43 | 6.19x | $832.15 | $3.2M | 20.0K | 2 |
| 2017 | $1.1K | $178.70 | 6.14x | $918.81 | $5.4M | 30.5K | 5 |
| 2018 | $273.74 | $71.09 | 3.85x | $202.65 | $5.4M | 75.8K | 16 |
| 2019 | $140.02 | $55.02 | 2.54x | $85.00 | $9.0M | 163.7K | 23 |
| 2020 | $131.90 | $53.47 | 2.47x | $78.43 | $7.5M | 139.5K | 18 |
| 2021 | $126.69 | $47.22 | 2.68x | $79.47 | $7.2M | 152.2K | 19 |
| 2022 | $98.48 | $43.26 | 2.28x | $55.22 | $8.0M | 183.8K | 24 |
| 2023 | $79.64 | $36.42 | 2.19x | $43.22 | $6.6M | 182.0K | 23 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 49.3K | $11.7M | $237.01 | 6.81x |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 212.5K | $7.5M | $35.13 | 1.69x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 62.4K | $4.8M | $77.04 | 1.99x |
| 87799 | Detection test by nucleic acid for organism, quantification | 95.9K | $4.3M | $44.92 | 1.57x |
| 87481 | Detection test for candida species (yeast), amplified probe technique | 100.7K | $3.6M | $35.47 | 1.67x |
| 87632 | Detection test for multiple types of respiratory virus | 10.9K | $2.4M | $223.38 | 1.57x |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 9.7K | $1.9M | $196.91 | 6.79x |
| 87482 | Detection test for candida species (yeast), quantification | 32.1K | $1.8M | $55.14 | 1.47x |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 43.7K | $1.6M | $36.17 | 1.62x |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 43.0K | $1.5M | $36.07 | 1.62x |
| 87652 | Detection test by nucleic acid for strep (streptococcus, group a), quantification | 31.4K | $1.4M | $43.74 | 1.57x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 55.1K | $1.4M | $24.83 | 2.01x |
| 87900 | Infectious agent drug susceptibility analysis | 8.6K | $1.3M | $148.68 | 1.35x |
| 80307 | Testing for presence of drug, by chemistry analyzers | 15.8K | $1.2M | $74.40 | 2.22x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 7.1K | $1.1M | $155.19 | 7.15x |
| 87497 | Detection test by nucleic acid for cytomegalovirus, quantification | 22.9K | $992.3K | $43.38 | 1.73x |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | 82.3K | $752.5K | $9.14 | 1.46x |
| G0479 | Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when | 7.6K | $589.0K | $77.66 | 2.00x |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 5.1K | $577.6K | $112.32 | 7.42x |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 12.2K | $424.2K | $34.69 | 1.71x |
This provider submits charges 3.17 times higher than what Medicare actually pays.
A markup ratio of 3.17x means for every $100 Medicare pays, this provider initially charges $317. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in MD for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Quest Diagnostics Incorporated Md | Baltimore, MD | $318.4M | ⚠️ Flagged |
| Genedx Llc | Gaithersburg, MD | $67.3M | ✓ Clear |
| Theranostix Inc | Beltsville, MD | $61.4M | ✓ Clear |
| Cirrus Dx, Inc. | Rockville, MD | $37.3M | ✓ Clear |
| Meritus Medical Laboratory Llc | Hagerstown, MD | $35.9M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data